Merck KGaA banner

Merck KGaA
OTC:MKGAF

Watchlist Manager
Merck KGaA Logo
Merck KGaA
OTC:MKGAF
Watchlist
Price: 129.45 USD -3.32% Market Closed
Market Cap: $56.3B

Profitability Summary

Merck KGaA's profitability score is 51/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score
51/100
Profitability
Score

Margins

Earnings Waterfall
Merck KGaA

Margins Comparison
Merck KGaA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Merck KGaA
XETRA:MRK
47B EUR
Loading...
Loading...
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
191.9B USD
Loading...
Loading...
Loading...
US
Danaher Corp
NYSE:DHR
140.5B USD
Loading...
Loading...
Loading...
DE
Basf Se
XETRA:BAS
39.4B EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
584.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
262.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
238.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.5B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
289.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Merck KGaA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Merck KGaA
XETRA:MRK
47B EUR
Loading...
Loading...
Loading...
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
191.9B USD
Loading...
Loading...
Loading...
Loading...
US
Danaher Corp
NYSE:DHR
140.5B USD
Loading...
Loading...
Loading...
Loading...
DE
Basf Se
XETRA:BAS
39.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
584.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
262.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
238.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
223.5B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
289.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Merck KGaA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett